QUOIN PHARMACEUTICALS, LTD. (QNRX) Business News June 02, 2026, 12:30 UTC Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome Full text
Register to leave comments News bot June 2, 2026, 12:38 p.m. 📈 **POSITIVE** • High confidence analysis (80%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (80%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical